XDNA.TO vs. LMAX.TO
XDNA.TO (iShares Genomics Immunology and Healthcare Index ETF) and LMAX.TO (Hamilton Healthcare Yield Maximizer ETF) are both Health & Biotech Equities funds. XDNA.TO is passively managed, while LMAX.TO is actively managed. Over the past year, XDNA.TO returned 40.18% vs 7.58% for LMAX.TO. At a 0.18 correlation, their price movements are largely independent. XDNA.TO charges 0.44%/yr vs 0.65%/yr for LMAX.TO.
Performance
XDNA.TO vs. LMAX.TO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XDNA.TO achieves a 10.45% return, which is significantly higher than LMAX.TO's -4.95% return.
XDNA.TO
- 1D
- -1.95%
- 1M
- -1.11%
- YTD
- 10.45%
- 6M
- 9.39%
- 1Y
- 40.18%
- 3Y*
- 7.28%
- 5Y*
- —
- 10Y*
- —
LMAX.TO
- 1D
- 1.06%
- 1M
- 1.95%
- YTD
- -4.95%
- 6M
- -6.28%
- 1Y
- 7.58%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
XDNA.TO vs. LMAX.TO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
XDNA.TO iShares Genomics Immunology and Healthcare Index ETF | 10.45% | 12.10% | 6.07% |
LMAX.TO Hamilton Healthcare Yield Maximizer ETF | -4.95% | 7.03% | 4.91% |
Correlation
The correlation between XDNA.TO and LMAX.TO is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Feb 8, 2024 | 0.18 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XDNA.TO vs. LMAX.TO — Risk / Return Rank
XDNA.TO
LMAX.TO
XDNA.TO vs. LMAX.TO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Genomics Immunology and Healthcare Index ETF (XDNA.TO) and Hamilton Healthcare Yield Maximizer ETF (LMAX.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XDNA.TO | LMAX.TO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.07 | ||
| Sortino ratioReturn per unit of downside risk | +1.55 | ||
| Omega ratioGain probability vs. loss probability | 1.30 | 1.11 | +0.19 |
| Calmar ratioReturn relative to maximum drawdown | 4.67 | 0.63 | +4.05 |
| Martin ratioReturn relative to average drawdown | 10.95 | 1.53 | +9.41 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| XDNA.TO | LMAX.TO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.65 | 0.58 | +1.07 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.04 | 0.21 | -0.17 |
Drawdowns
XDNA.TO vs. LMAX.TO - Drawdown Comparison
The maximum XDNA.TO drawdown since its inception was -45.90%, which is greater than LMAX.TO's maximum drawdown of -15.87%. Use the drawdown chart below to compare losses from any high point for XDNA.TO and LMAX.TO.
Loading charts...
Drawdown Indicators
| XDNA.TO | LMAX.TO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.90% | -15.87% | -30.03% |
Max Drawdown (1Y)Largest decline over 1 year | -8.64% | -12.16% | +3.52% |
Max Drawdown (3Y)Largest decline over 3 years | -28.29% | — | — |
Current DrawdownCurrent decline from peak | -8.95% | -9.67% | +0.72% |
Average DrawdownAverage peak-to-trough decline | -23.55% | -5.21% | -18.34% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.68% | 4.95% | -1.27% |
Volatility
XDNA.TO vs. LMAX.TO - Volatility Comparison
iShares Genomics Immunology and Healthcare Index ETF (XDNA.TO) has a higher volatility of 6.47% compared to Hamilton Healthcare Yield Maximizer ETF (LMAX.TO) at 4.38%. This indicates that XDNA.TO's price experiences larger fluctuations and is considered to be riskier than LMAX.TO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XDNA.TO | LMAX.TO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.47% | 4.38% | +2.09% |
Volatility (6M)Calculated over the trailing 6-month period | 18.03% | 9.50% | +8.53% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.71% | 13.23% | +11.48% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.32% | 13.71% | +11.61% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.32% | 13.71% | +11.61% |
XDNA.TO vs. LMAX.TO - Expense Ratio Comparison
XDNA.TO has a 0.44% expense ratio, which is lower than LMAX.TO's 0.65% expense ratio.
Dividends
XDNA.TO vs. LMAX.TO - Dividend Comparison
XDNA.TO's dividend yield for the trailing twelve months is around 0.39%, less than LMAX.TO's 13.45% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
LMAX.TO Hamilton Healthcare Yield Maximizer ETF | 13.45% | 12.51% | 11.36% | 0.00% | 0.00% |
XDNA.TO iShares Genomics Immunology and Healthcare Index ETF | 0.39% | 0.43% | 0.32% | 0.25% | 0.32% |
Frequently Asked Questions
XDNA.TO and LMAX.TO have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XDNA.TO is cheaper at 0.44% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XDNA.TO is cheaper with a 0.44% expense ratio, compared with 0.65% for LMAX.TO.
They also come from different issuers: iShares and Hamilton. Their fees differ too: 0.44% for XDNA.TO and 0.65% for LMAX.TO.
Find the right allocation for XDNA.TO and LMAX.TO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer